首页> 外文OA文献 >Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

【2h】

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

机译：贝沙罗汀（一种增加载脂蛋白-E的化合物）治疗对突变APP / PS1小鼠没有任何认知益处

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Katherine D LaClair; Kebreten F Manaye; Dexter L Lee; Joanne S Allard; Alena V Savonenko; Juan C Troncoso; Philip C Wong;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Correction: treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice [J] . Katherine D LaClair, Kebreten F Manaye, Dexter L Lee, Molecular neurodegeneration . 2013,第S1期

机译：校正：使用贝沙罗汀（增加载脂蛋白-E的化合物）治疗对突变的APP / PS1小鼠没有认知作用
2. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice [J] . Katherine D LaClair, Kebreten F Manaye, Dexter L Lee, Molecular neurodegeneration . 2013,第S1期

机译：贝沙罗汀（一种增加载脂蛋白-E的化合物）治疗对突变的APP / PS1小鼠没有任何认知益处
3. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice [J] . Chunling Yuan, Xiaoli Guo, Qifan Zhou, Biochimica et biophysica acta. Molecular basis of disease: BBA . 2019,第1期

机译：oab-14，一种北芳烯衍生物，通过增加APP / PS1小鼠中的β-淀粉样蛋白清除来改善阿尔茨海默病相关病理和认知障碍
4. Cerebral blood microcirculation measurement in APP/PS1 double transgenic mice at the preclinical stage of Alzheimer’s disease: preliminary data on the early intervention of anodal transcranial direct current stimulation * [C] . Yin P. Luo, Li Zhang, Xiao Y. Wu, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2020

机译：在阿尔茨海默氏病临床前期对APP / PS1双转基因小鼠进行脑血微循环测量：阳极经颅直流电刺激的早期干预的初步数据*
5. The effects of a novel oral-vaccine targeted against the RAGE-Abeta complex immunogen on Alzheimer's disease like pathology and cognitive function in APP/PS1 mice. [D] . Webster, Scott J. 2012

机译：针对RAGE-Abeta复合免疫原的新型口服疫苗对APP / PS1小鼠的阿尔茨海默氏病（如病理学和认知功能）的影响。
6. Treatment with bexarotene a compound that increases apolipoprotein-E provides no cognitive benefit in mutant APP/PS1 mice [O] . Katherine D LaClair, Kebreten F Manaye, Dexter L Lee, 2013

机译：贝沙罗汀（一种增加载脂蛋白-E的化合物）治疗对突变APP / PS1小鼠没有任何认知益处
7. Correction: treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice [O] . Katherine D LaClair, Kebreten F Manaye, Dexter L Lee, 2013

机译：校正：使用贝沙罗汀（增加载脂蛋白-E的化合物）治疗对突变APP / PS1小鼠没有认知作用

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

著录项

引文网络

相似文献

相关主题

期刊订阅